OptiBiotix Health plc (AIM: OPTI) – further contract signed with NIZO Food Research
Today OptiBiotix, a life sciences business, has announced that it has signed a third agreement with NIZO Food Research BV ("NIZO"), the contract food research organisation based in the Netherlands.
We reported on OptiBiotix last week, it is a very exciting new business operating in one of the most progressive areas of biotechnological research. It aims to develop compounds which modify the human microbiome to help combat obesity, diabetes and high cholesterol. Using its technology platforms for microbiome modulation, the Group has generated three research programmes which they are developing in the functional foods and health supplements marketplace. The projects are a weight management formulation, a cholesterol reducing microbial strain and novel calorie free sugars. Today’s announcement impacts the final project, the novel sugars. This project is only at very…